Serum levels of interleukin‐34 and clinical correlation in patients with primary Sjögren's syndrome. (10th December 2019)

• Record Type: Journal Article
• Authors: Liu, Yanmei; Zhang, Bei; Lei, Yimeng; Xia, Liping; Lu, Jing; Shen, Hui
• Is Part Of: International journal of rheumatic diseases. Volume 23:Number 3(2020)
• Page Start: 374
• Page End: 380
• Publication Date: 2019-12-10
• Subjects: autoantibody -- clinical correlation -- immunoglobulin -- interleukin‐34 -- primary Sjögren's syndrome; Rheumatology -- Periodicals; Rheumatology -- Asia -- Periodicals; Rheumatology -- Pacific Area -- Periodicals; Rheumatic Diseases -- Periodicals; Connective Tissue Diseases -- Periodicals; Immune System Diseases -- Periodicals; 616.723
• DOI: 10.1111/1756-185X.13773
• Languages: English
• ISSNs: 1756-1841

Abstract

Abstract: Objectives: To measure the levels of serum interleukin (IL)‐34 in patients with primary Sjögren's syndrome (pSS) and evaluate the cytokine's clinical association with the disease. Methods: Serum samples were obtained from 66 pSS patients and 32 healthy controls (HCs) and measured by enzyme‐linked immunosorbent assay for IL‐34 levels. The clinical parameters, including autoantibodies, immunoglobulins (Igs), complements (Cs), inflammatory indicators, involvement of the blood system, lung and arthritis, were collected simultaneously. Two‐sample t test was applied for comparison between 2 groups, and Pearson's correlation coefficient was used to assess the associations between IL‐34 levels and laboratory parameters. Results: Serum IL‐34 levels were significantly elevated in pSS patients compared with HCs. Patients with anti‐Ro/SSA antibody positivity showed higher serum IL‐34 levels than those who were negative, as did the anti‐La/SSB antibody‐positive patients. Serum IL‐34 levels were positively associated with the levels of rheumatoid factor, IgG and gamma‐globulin, but not associated with IgA, IgM, C3, C4, erythrocyte sedimentation rate or C‐reactive protein. For the pSS subgroups with and without leucopenia, thrombocytopenia, anemia or interstitial lung disease (ILD), there was no significant difference in serum IL‐34 levels. Interestingly, the pSS patients with arthritis had higher levels of IL‐34 compared with the no‐arthritis patients. Conclusions: IL‐34 may be involved in B cell activation and production of antibodies in pSS.